ArticleFrontiers in nutrition2026
A novel nutritional immune risk score model for long-term prognosis in colorectal cancer using clustering and principal component analysis.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Admission nutritional-immunological indices and sepsis risk in emergency trauma patients: a retrospective cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Survival outcomes among patients with colorectal cancer (CRC) often differ despite identical disease stages, partly due to variations in nutritional and immune status. Malnutrition can impair immune defense, exacerbate inflammatory responses, and influence tumor progression, ultimately contributing to a poorer prognosis. However, current clinical prognostic systems rarely integrate nutritional immune indicators with tumor biomarkers, limiting the application of nutritional intervention in CRC management. This study aimed to develop a nutritional immune risk score (NIRS) model to improve long-term prognostic evaluation in patients with CRC. Methods: In this retrospective study, 892 inpatients with primary CRC who underwent curative resection in 2017 were included and followed until 2023. Unsupervised learning was applied to nutritional and tumor biomarkers for feature extraction and patient stratification. K-means clustering was used to identify subgroups, and principal component analysis was used to derive composite features, which were then used to construct the NIRS model for long-term prognostic assessment. Results: Four variables-prognostic nutritional index (PNI), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 72-4 (CA72-4)-were selected for model construction. The final model was defined as: NIRS = 0.572 × PNI - 0.101 × CEA - 0.412 × CA19-9 - 0.028 × CA72-4. Using an optimal cutoff value of 21.34, patients were stratified into a low-risk group and a high-risk group. The Kaplan-Meier analysis showed that patients in the low-risk group had significantly better overall survival than those in the high-risk group ( Conclusion: We developed a novel NIRS for long-term prognostic assessment in patients with CRC. The NIRS model demonstrated robust risk stratification and potential clinical utility. PNI may serve as a complementary factor to refine risk classification, and its interaction with maximum tumor diameter may improve the sensitivity and precision of prognostic assessment across different nutritional immune states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.